Angioplasty percutaneous

Abciximab (ReoPro) is the Fab fragment of a humanized monoclonal antibody directed against the a bp3 receptor. It also binds to the vitronectin receptor on platelets, vascular endothelial cells, and smooth-muscle cells. The antibody is used in conjunction with percutaneous angioplasty for coronary thromboses, and when used in conjunction with aspirin and heparin, has been shown to be quite effective in preventing restenosis, recurrent myocardial infarction, and death. [Pg.35]

Glanz S, Gordon DH, Lipkowitz GS et al. (1980) Axillary and subclavian vein stenosis percutaneous angioplasty. Radiology 168 371-373... [Pg.131]

Rosch J, Uchida BD, Hall LD et al. (1992) Gianturco-Rdsch expandable Z stents in the treatment of superior vena cava syndrome. Cardiovasc Intervent Radiol 15 319-327 Saced M, Newman GE, McCavin RL et al. (1987) Stenoses in dialysis fistulas treatment with percutaneous angioplasty. Radiology 164 693-697... [Pg.131]

Barath P, Fishbein MC, Vari S, Forrester JS (1991) Cutting balloon a novel approach to percutaneous angioplasty. Am J Cardiol 68 1249-1252... [Pg.492]

GPIIb/IIIa antagonists have to be administered parenterally. They are currently used prophylactically during intracoronary interventions such as percutaneous transluminal revascularization with balloon angioplasty or intracoronary stenting, as well as to treat acute coronary syndromes like unstable angina and acute myocardial infarction. The main complications... [Pg.170]

Percutaneous coronary intervention (PCI) is one of a host of techniques performed by using a catheter inserted via a major limb artery that aims to relieve nanowing of coronary arteries. For example, percutaneous transluminal coronary angioplasty (PTCA) is the classic PCI that uses a catheter-directed balloon to dilate a stenotic coronary artery, and more recent PCIs include stent implantation, rotational atherectomy, and laser angioplasty. [Pg.938]

Ueda T, Hatakeyama T, Kohno K, Kumon Y, Sakaki S. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997 39 99-104. [Pg.91]

Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion an alternative option to intra-arterial thrombolysis. Stroke 2002 33 2872-2876. [Pg.95]

PT Pertussis toxin PTCA Percutaneous transluminal coronary angioplasty PTCR Percutaneous transluminal coronary recanalization Pte-H Tetrahydropteridine PUFA Polyunsaturated fatty acid PUMP-1 Punctuated metalloproteinase also known as matrilysin... [Pg.285]

Coronary interventions (coronary bypass, percutaneous transluminal coronary angioplasty, or stents)... [Pg.181]

PTCA Percutaneous transluminal coronary angioplasty Sao2 Arterial oxygen percent saturation... [Pg.1557]

Cardiac catheterization and coronary angiography are used in patients with suspected CAD to document the presence and severity of disease as well as for prognostic purposes. Interventional catheterization is used for thrombolytic therapy in patients with acute MI and for managing patients with significant CAD to relieve obstruction through percutaneous transluminal coronary angioplasty, atherectomy, laser treatment, or stent placement. [Pg.146]

Perchlorotoluene, 6 327 Perchlorylation, 12 183 Perchloryl fluoride, 18 279 Percolation leaching, 16 153 Percolation processes of filled polymers, 11 303 for wood, 26 358-359 Percolation theory, 20 345 23 63 Percolation transition, 10 16 Percutaneous transluminal coronary angioplasty (PTCA), 3 712 -per- designation, 7 609t PE resins, applications of, 20 206t. See also Polyethylene (PE)... [Pg.681]

Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996 28 1127-1133. [Pg.202]

The safety and efficacy of bivalirudin have not been established in patients with acute coronary syndromes who are not undergoing percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI). [Pg.157]

PTCA percutaneous transluminal coronary angioplasty PTH parathyroid hormone PTT partial thromboplastin time PUD peptic ulcer disease pulm pulmonary PVC premature ventricular contraction... [Pg.449]

Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris outcomes for patients with double-vessel versus single—vessel coronary artery disease in a Vererans Affairs cooperative randomized trial. J Am Coll Cardiol 1997 29 1505. [Pg.81]

Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease in-hospital results and 1 year follow-up. J Am Coll Cardiol 1993 22 1060. [Pg.82]

Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction a 3 year experience. J Am Coll Cardiol 1987 10 264-272. [Pg.82]

Maillard L, Hamon M, Khalife K, et al. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000 35 1729-1736. [Pg.83]

Lefkovits J, Ivanhoe RJ, Califf RM, et al. Effects of platelet glycoprotein llb/llla receptor blockade by a chimeric monoclonal antibody on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction (EPIC). Am J Cardiol 1996 77 1045-1051. [Pg.83]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...